IVC Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Buy
5,201
+6
+0.1% +$345 0.12% 138
2026
Q1
$315K Sell
5,195
-2
-0% -$117 0.14% 124
2025
Q4
$280K Sell
5,197
-25
-0.5% -$1.2K 0.12% 139
2025
Q3
$236K Sell
5,222
-283
-5% -$13.2K 0.11% 159
2025
Q2
$255K Buy
5,505
+738
+15% +$36.2K 0.12% 144
2025
Q1
$291K Sell
4,767
-127
-3% -$7.4K 0.16% 127
2024
Q4
$277K Sell
4,894
-469
-9% -$26.2K 0.15% 128
2024
Q3
$277K Sell
5,363
-217
-4% -$10.2K 0.15% 128
2024
Q2
$232K Buy
+5,580
New +$250K 0.13% 148
2024
Q1
Sell
-4,000
Closed -$205K 165
2023
Q4
$205K Sell
4,000
-4,367
-52% -$229K 0.13% 154
2023
Q3
$486K Sell
8,367
-624
-7% -$38.2K 0.32% 75
2023
Q2
$575K Buy
8,991
+140
+2% +$9.39K 0.36% 70
2023
Q1
$613K Sell
8,851
-128
-1% -$9.03K 0.43% 64
2022
Q4
$646K Buy
8,979
+174
+2% +$13.1K 0.48% 61
2022
Q3
$626K Sell
8,805
-137
-2% -$9.94K 0.5% 58
2022
Q2
$689K Buy
8,942
+105
+1% +$8K 0.53% 53
2022
Q1
$645K Buy
8,837
+574
+7% +$38.5K 0.42% 61
2021
Q4
$515K Buy
8,263
+270
+3% +$15.8K 0.33% 79
2021
Q3
$473K Sell
7,993
-250
-3% -$16.5K 0.33% 77
2021
Q2
$551K Sell
8,243
-1,925
-19% -$126K 0.39% 72
2021
Q1
$642K Buy
10,168
+75
+0.7% +$4.67K 0.51% 57
2020
Q4
$626K Buy
+10,093
New +$621K 0.6% 47

Other funds holding BMY

IVC Wealth Advisors's BMY Position: Q2 2026 in Review

IVC Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.12% in Q2 2026, buying an estimated $345 and bringing the position to 5,201 shares worth $300K. The position accounts for 0.12% of the portfolio, ranked #138.

IVC Wealth Advisors first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $689K in Q2 2022. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • IVC Wealth Advisors held 5,201 shares of Bristol-Myers Squibb worth $300K as of Q2 2026.
  • IVC Wealth Advisors bought 6 Bristol-Myers Squibb shares in Q2 2026, an estimated $345.
  • Bristol-Myers Squibb made up 0.12% of IVC Wealth Advisors's portfolio in Q2 2026, its #138 holding.
  • IVC Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • IVC Wealth Advisors's Bristol-Myers Squibb position peaked at $689K in Q2 2022.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on IVC Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.